Αποτελέσματα Αναζήτησης
DESCRIPTION. Methergine® (methylergonovine maleate) is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum hemorrhage. Methergine is available in sterile ampuls of...
Pregnancy . Category C. Animal reproductive studies have not been conducted with Methergine. It is also not known whether methylergonovine maleate can cause fetal harm or can affect reproductive...
Pregnancy Safer, and Essential Medicines and Pharmaceutical Policies drafted questions on interventions and a list of possible outcomes in the treatment of atonic postpartum haemorrhage and retained placenta (Annex 1).
The following guideline provides a comprehensive document re-garding best practice for the prevention and treatment of postpartum hemorrhage (PPH) in low-resource settings. FIGO is actively contributing to the global effort to reduce maternal death and disability around the world.
The administration of uterotonic drugs to prevent PPH is the main intervention within this package and can prevent two-thirds of PPH. 6,10 Uterotonics are also essential for the treatment of PPH, but treatment is not the focus of this review. Several different uterotonic drugs have been used for preventing PPH.
17 Μαρ 2022 · The purpose of this document is to update key concepts in the management of postpartum hemorrhage (PPH) and give clear and precise tools to health personnel in low- and middle-income countries (LMICs) to perform evidence-based treatments, with the aim of reducing related maternal morbidity and mortality.
The framework for management of PPH includes women with PPH immediately post-birth to 12 weeks postpartum following pregnancy of > 24 weeks' gestation. The figure depicts the KQs within the context of the PICOTS described in the document.
